Park Y H, Yoshida Y, Uchino H, Miyama-Inaba M, Masuda T
Cell Immunol. 1985 Jun;93(1):58-67. doi: 10.1016/0008-8749(85)90388-0.
Immunofluorescent studies using fluorescein isothiocyanate-conjugated mouse anti-allotype antibody were carried out to study the migration pattern and the development of surface Ig (SIg), Fc receptor for IgG (FcR gamma), and complement receptor (CR) or mouse bone marrow lymphocytes following intravenous injection into congenic mice. After transfer of bone marrow cells from CSW mice into untreated congenic CWB mice, the absolute number of donor-type SIg-bearing (SIg+) cells and the proportion of either FcR gamma- or CR-bearing (FcR gamma+ or CR+) cells in donor-type SIg+ cells were evaluated in the recipient spleen and the results were compared with those obtained after the transfer of CSW spleen cells. After injection of donor bone marrow cells, detectable donor-type SIg+ cells, although few initially, increased from day 1 to Day 2 and reached a plateau thereafter. The proportion of FcR gamma+ cells in donor-type SIg+ cells, although very low in the donor marrow inoculum, increased progressively after 1 day to reach a maximum at Day 5 (90%). On the other hand, following the transfer of spleen cells, the proportion of FcR gamma+ cells remained at high levels (90%) for 5 days after transfer. Likewise, the proportion of CR+ cells in donor-type SIg+ cells was very low (less than 1%) in the original donor bone marrow cells but high (60%) in the donor spleen cells. However, in transferring bone marrow cells this proportion also increased in the recipient spleen to reach a maximum (49%) at Day 5 although it was lower compared to the percentage of FcR gamma+ cells in donor SIg+ cells. Furthermore, the ability of functional responsiveness to antigen was also examined in the same system by detecting plaque-forming cells (PFC) from donor origin. In transferring donor bone marrow cells into recipient, the participation of donor cells in the PFC response was very low when the recipients were primed with sheep red blood cells at Day 3 after transfer. However, when the recipients were primed at Days 7 to 21 after transfer, increasing numbers of the donor marrow-derived cells were involved in the PFC response. Thus, the present study demonstrates that the bone marrow-derived lymphocytes, albeit lacking both distinctive surface receptors (IgM, FcR gamma, CR) and the functional responsiveness to antigen, continue their development along the B-cell lineage after migrating into the spleen, as evidenced by the surface receptor expression and participation in the antibody response.
采用异硫氰酸荧光素偶联的小鼠抗同种异型抗体进行免疫荧光研究,以探讨静脉注射到同基因小鼠体内的小鼠骨髓淋巴细胞的迁移模式以及表面免疫球蛋白(SIg)、IgG的Fc受体(FcRγ)和补体受体(CR)的发育情况。将CSW小鼠的骨髓细胞移植到未经处理的同基因CWB小鼠体内后,评估受体脾脏中供体型携带SIg(SIg+)细胞的绝对数量以及供体型SIg+细胞中携带FcRγ或CR(FcRγ+或CR+)细胞的比例,并将结果与CSW脾细胞移植后获得的结果进行比较。注射供体骨髓细胞后,可检测到的供体型SIg+细胞虽然最初很少,但从第1天到第2天增加,并在之后达到平台期。供体型SIg+细胞中FcRγ+细胞的比例,虽然在供体骨髓接种物中非常低,但在1天后逐渐增加,在第5天达到最大值(90%)。另一方面,在脾细胞移植后,FcRγ+细胞的比例在移植后5天内保持在高水平(90%)。同样,供体型SIg+细胞中CR+细胞的比例在原始供体骨髓细胞中非常低(不到1%),但在供体脾细胞中很高(60%)。然而,在移植骨髓细胞时,该比例在受体脾脏中也增加,在第5天达到最大值(49%),尽管与供体SIg+细胞中FcRγ+细胞的百分比相比要低。此外,还通过检测供体来源的噬斑形成细胞(PFC)在同一系统中检查了对抗原的功能反应性。在将供体骨髓细胞移植到受体中时,当受体在移植后第3天用绵羊红细胞进行免疫时,供体细胞在PFC反应中的参与度非常低。然而,当受体在移植后第7至21天进行免疫时,越来越多的供体骨髓来源细胞参与了PFC反应。因此,本研究表明,骨髓来源的淋巴细胞虽然缺乏独特的表面受体(IgM、FcRγ、CR)和对抗原的功能反应性,但在迁移到脾脏后仍沿B细胞谱系继续发育,表面受体表达和参与抗体反应证明了这一点。